FDA Inspection 909274 — Jubilant Draximage Radiopharmacies Inc

Jubilant Draximage Radiopharmacies Inc — FEI 3008364285

The FDA completed an inspection of Jubilant Draximage Radiopharmacies Inc on Jan 9, 2015 in Kansas City, MO. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). 4 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Official Action Indicated (OAI)
End Date
Jan 9, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Kansas City, MO (United States)

Citations

IDCFRDescription
110521 CFR 211.22(d)Procedures not in writing, fully followed
115921 CFR 211.28(a)Clothing appropriate for duties performed
142121 CFR 211.42(c)(10)Aseptic Processing Area
360321 CFR 211.160(b)Scientifically sound laboratory controls

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.